Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy
Uncommon response during immunotherapy is a new challenging issue in oncology practice. Recently, new criteria for evaluation of response to immunotherapy immune response evaluation criteria in solid tumors (iRECIST) were accepted. According to iRECIST, worsening of performance status (PS) accompani...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sciendo
2018-10-01
|
| Series: | Radiology and Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.2478/raon-2018-0037 |
| _version_ | 1818596997399052288 |
|---|---|
| author | Vrankar Martina Unk Mojca |
| author_facet | Vrankar Martina Unk Mojca |
| author_sort | Vrankar Martina |
| collection | DOAJ |
| description | Uncommon response during immunotherapy is a new challenging issue in oncology practice. Recently, new criteria for evaluation of response to immunotherapy immune response evaluation criteria in solid tumors (iRECIST) were accepted. According to iRECIST, worsening of performance status (PS) accompanied to pseudoprogression reflects most probably the true progression of the malignant disease. |
| first_indexed | 2024-12-16T11:40:48Z |
| format | Article |
| id | doaj.art-f3f73bfee62f4fe29d8a3c06ec198516 |
| institution | Directory Open Access Journal |
| issn | 1581-3207 |
| language | English |
| last_indexed | 2024-12-16T11:40:48Z |
| publishDate | 2018-10-01 |
| publisher | Sciendo |
| record_format | Article |
| series | Radiology and Oncology |
| spelling | doaj.art-f3f73bfee62f4fe29d8a3c06ec1985162022-12-21T22:32:57ZengSciendoRadiology and Oncology1581-32072018-10-0152436536910.2478/raon-2018-0037raon-2018-0037Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapyVrankar Martina0Unk Mojca1Department of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, SloveniaDepartment of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, SloveniaUncommon response during immunotherapy is a new challenging issue in oncology practice. Recently, new criteria for evaluation of response to immunotherapy immune response evaluation criteria in solid tumors (iRECIST) were accepted. According to iRECIST, worsening of performance status (PS) accompanied to pseudoprogression reflects most probably the true progression of the malignant disease.https://doi.org/10.2478/raon-2018-0037symptomatic pseudoprogressionatypical responseimmunotherapylung cancer |
| spellingShingle | Vrankar Martina Unk Mojca Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy Radiology and Oncology symptomatic pseudoprogression atypical response immunotherapy lung cancer |
| title | Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy |
| title_full | Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy |
| title_fullStr | Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy |
| title_full_unstemmed | Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy |
| title_short | Immune RECIST criteria and symptomatic pseudoprogression in non-small cell lung cancer patients treated with immunotherapy |
| title_sort | immune recist criteria and symptomatic pseudoprogression in non small cell lung cancer patients treated with immunotherapy |
| topic | symptomatic pseudoprogression atypical response immunotherapy lung cancer |
| url | https://doi.org/10.2478/raon-2018-0037 |
| work_keys_str_mv | AT vrankarmartina immunerecistcriteriaandsymptomaticpseudoprogressioninnonsmallcelllungcancerpatientstreatedwithimmunotherapy AT unkmojca immunerecistcriteriaandsymptomaticpseudoprogressioninnonsmallcelllungcancerpatientstreatedwithimmunotherapy |